Evaluation of two commercial procedures for quantification of human immunodeficiency virus type 1 RNA with respect to HIV-1 viral subtype and antiviral treatment

Clinical Laboratory

Volumn 46, Issue 7-8, 2000, Pages 355-360

  Schmid, I ^a   Arrer, E ^a   Hawranek, T ^a   Patsch, W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

HIV 1 antiviral treatment; HIV 1 RNA; HIV 1 viral subtype

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARDIZATION; TECHNIQUE; TIME; VIRUS CHARACTERIZATION; VIRUS LOAD; VIRUS TYPING;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; AUSTRIA; CONTINENTAL POPULATION GROUPS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; SEROTYPING;

ANIMALIA; CHIRON; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; UNIDENTIFIED BACTERIOPHAGE;

EID: 0033912550     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Acute human immunodeficiency virus type 1 infection
2. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
3. HIV-1 viral load and clinical outcome
4. Monitoring plasma HIV-RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team
5. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure
6. Veterans Affairs Cooperative Study Group on AIDS. Changes in plasma HIV - RNA and CD4+ lymphocyte counts and the risk of progression to AIDS
7. HIV viral load markers in clinical practice
8. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy
9. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter
10. The duration of viral suppression during proteinase inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir
11. Human immunodeficiency virus (HIV) disease: AIDS and related disorders P.
12. Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and beteroduplex mobility assay: Evidence of increasing infection with HIV-1 subtype E.
13. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ ml
14. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection
15. Preparation and characterization of RNA standards for use in branched DNA hybridization assays
16. Serotyping of HIV type 1 infections: Definition, relationship to viral genetic subtypes and assay evaluation